Home » Newsletters » BioWorld Science

BioWorld Science

April 7, 2020

View Archived Issues

Smart bacterium senses environment

The dose makes the poison -- timing, too

Head and neck cancer cachexia mouse model developed

Large-scale proteomic analysis unveils a shift in glutaminate fate involved in cancer progression

GRASP55 plays a key physiological role in intestinal lipid uptake

Ennaid begins development of ENU-200 for COVID-19 infection

Glycoprotein negatively regulates adult neurogenesis

First patient dosed in phase I study of COM-902 in advanced malignancies

Opaganib approved for compassionate use in patients with COVID-19 in Italy

Millendo Therapeutics discontinues development of livoletide for PWS

European Commission approves Nilemdo and Nustendi

AXS-07 achieves both coprimary endpoints in INTERCEPT phase III study

Mesoblast's IND for remestemcel-L in COVID-19-related ARDS receives clearance

IRF-1 as a novel therapeutic target in CKD

Novel alpha-ketoamide inhibitor with activity against main protease of SARS-CoV-2

Ono Pharmaceutical divulges PTGDR2 antagonists

Chinese researchers patent compounds for cancer

Bristol-Myers Squibb synthesizes new LPA1 receptor antagonists

Hanmi Science presents new EGFR mutant inhibitors

Pfizer discloses new CCR6 antagonists

FDA accepts IND for phase I testing of INO-4800 for COVID-19

FDA clears IND application for EIDD-2801 for COVID-19

SARS-CoV-2 vaccine shows promise in first peer-reviewed article on a potential COVID-19 vaccine

PKX-001 demonstrates safety and efficacy in dry eye disease model

Crinetics reports interim data from phase II ACROBAT EDGE trial of paltusotine in acromegaly

Aviptadil enters clinical trials to treat COVID-19-related ARDS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...